How to treat coronary heart disease and ischemic cardiomyopathy

summary

The heart is our body's power source, will have the energy the blood through the artery blood vessel transportation to the whole body each place, but the old people's body function drops, can appear the coronary heart disease ischemic cardiomyopathy, and everybody shares the coronary heart disease ischemic cardiomyopathy's treatment method.

How to treat coronary heart disease and ischemic cardiomyopathy

Method 1: heart transplantation drugs for severe advanced coronary heart disease, especially left ventricular ejection fraction (LVEF) < 20% of the patients, the effect is very poor, so heart transplantation has become an important treatment for this kind of disease, and the treatment effect is very good. However, due to cardiogenic reasons, the number of patients who can receive heart transplantation is only about 38% of the total number of patients who need heart transplantation. 2% or 39. About 5%, about 20%. 4% - 35% of the recipients died while waiting for the donor. Therefore, there is an urgent need to find other treatment methods besides heart transplantation, and coronary artery bypass grafting and ventricular assist device have been widely used in clinic as a bridge waiting for heart transplantation.

Method 2: coronary artery bypass grafting (CABG) for ischemic cardiomyopathy, the key to success of CABG is to have enough viable myocardium, that is, more and more hibernating myocardium and stunned myocardium remain. Now the level of operation is higher and higher, almost 100% success. Positron emission computed tomography (PEF) is helpful to detect the remaining viable myocardium. Recently, McFall used PET to detect the uptake rate of (18) - F-FDG in 20 patients with ischemic cardiomyopathy (LVEF 27%) before and after CABG, especially in the anterior wall of left ventricle. It was found that McFall could evaluate the improvement of LVEF more objectively.

Method 3: atrioventricular valvuloplasty or replacement. From 1993 to 1998, Gangemi studied the surgical treatment of ischemic cardiomyopathy with severe mitral regurgitation. The one-year survival rate of these patients is less than 20% if they are treated with drugs, while the number of patients who can receive heart transplantation is limited. The researchers divided these patients (LVEF < 25%) into three groups: group I received mitral valve repair and CABG with severe mitral regurgitation; group II received CABG only; and group III received heart transplantation since 1993. The results showed that the in-hospital mortality of group I, II and III was 6. 3%、4。 However, LVEF in group I did not change, but in group II increased by 11%. 7%。

matters needing attention

People with coronary heart disease in life do not do very tired physical labor, and should pay attention to bed rest, not too much food, especially high-fat food, especially difficult to digest, can greatly increase the burden of the heart, make abdominal flatulence, diaphragm position rise, thus limiting the normal contraction and relaxation of the heart.